D
Dale G. Renlund
Researcher at University of Utah
Publications - 200
Citations - 11055
Dale G. Renlund is an academic researcher from University of Utah. The author has contributed to research in topics: Transplantation & Heart transplantation. The author has an hindex of 56, co-authored 200 publications receiving 10629 citations. Previous affiliations of Dale G. Renlund include Primary Children's Hospital & Veterans Health Administration.
Papers
More filters
Journal Article
Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy.
David O. Taylor,Michael R. Bristow,John B. O'Connell,Price Gd,Elizabeth H. Hammond,Donald B. Doty,Shreekanth V. Karwande,Kent W. Jones,Donald L Lappe,Dale G. Renlund +9 more
TL;DR: Successful early corticosteroid withdrawal identifies a subgroup of "immunologically privileged" patients with a low risk for long-term mortality and is not associated with an increased prevalence of late rejection or clinically significant coronary artery disease.
Journal ArticleDOI
Left ventricular assist device malfunction: a systematic approach to diagnosis.
Steven C. Horton,Reza A Khodaverdian,A.J Powers,James Revenaugh,James Revenaugh,Dale G. Renlund,Dale G. Renlund,Stephanie A. Moore,B.Y. Rasmusson,Karl E. Nelson,James W. Long +10 more
TL;DR: As LVAD use for treatment of end-stage HF becomes widespread and durations of support are extended, dysfunction will be increasingly prevalent and this catheter-based protocol provided a practical method to diagnose multiple causes of LVAD dysfunction.
Journal ArticleDOI
Method for isolation of human ventricular myocytes from single endocardial and epicardial biopsies.
G. A. Peeters,Michael C. Sanguinetti,Y. Eki,H. Konarzewska,Dale G. Renlund,Shreekanth V. Karwande,William H. Barry +6 more
TL;DR: In this article, the authors describe techniques for the isolation of Ca(2+)-tolerant adult human ventricular cells from both transvenous endomyocardial and epicardial biopsies.
Journal ArticleDOI
A Clinical Correlation Study of Severity of Antibody-mediated Rejection and Cardiovascular Mortality in Heart Transplantation
Abdallah G. Kfoury,Abdallah G. Kfoury,Dale G. Renlund,Dale G. Renlund,Dale G. Renlund,Gregory L. Snow,Josef Stehlik,Josef Stehlik,Josef Stehlik,Jan W. Folsom,Jan W. Folsom,Patrick W. Fisher,Patrick W. Fisher,Bruce B. Reid,Bruce B. Reid,Stephen E. Clayson,Stephen E. Clayson,Edward M. Gilbert,Edward M. Gilbert,Melanie D. Everitt,Melanie D. Everitt,Feras Bader,Feras Bader,Arun K. Singhal,Arun K. Singhal,M. Elizabeth H. Hammond +25 more
TL;DR: The severity of AMR on EMBs correlates with an incremental cardiovascular mortality risk after heart transplantation, suggesting that AMR should be viewed as a spectrum rather than just as present or absent.
Journal ArticleDOI
Prevalence and risks of allosensitization in HeartMate left ventricular assist device recipients: The impact of leukofiltered cellular blood product transfusions
Stavros G. Drakos,James C. Stringham,James C. Stringham,James W. Long,Edward M. Gilbert,Edward M. Gilbert,Thomas C. Fuller,Thomas C. Fuller,Beverly K. Campbell,Benjamin D. Horne,M.E Hagan,Karl E. Nelson,Judy M. Lindblom,Patty A. Meldrum,Joanne F. Carlson,Joanne F. Carlson,Stephanie A. Moore,Abdallah G. Kfoury,Dale G. Renlund,Dale G. Renlund +19 more
TL;DR: Cellular blood product transfusions may be associated with lessened alloimmunization and may mitigate the sensitization seen in recipients of the HeartMate left ventricular assist device as a bridge to transplantation.